(Q36411988)

English

DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

14 August 2017

DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications (English)

1 reference

stated in

Europe PubMed Central

14 August 2017

2

George F Atweh

1 reference

stated in

Europe PubMed Central

14 August 2017

Hassana Fathallah

1

1 reference

stated in

Europe PubMed Central

14 August 2017

2 March 2006

1 reference

stated in

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

20

1 reference

stated in

Europe PubMed Central

14 August 2017

4

1 reference

stated in

Europe PubMed Central

14 August 2017

227-234

1 reference

stated in

Europe PubMed Central

14 August 2017

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(00)81656-6

5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1128/MCB.25.11.4727-4741.2005

Identifiers

DOI

10.1016/J.BLRE.2006.01.002

1 reference

stated in

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

PubMed ID

16513230

retrieved

14 August 2017

(Q36411988)

DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)